_version_ 1783537051419803648
author Moon, Andrew M.
Webb, Gwilym J.
Aloman, Costica
Armstrong, Matthew J.
Cargill, Tamsin
Dhanasekaran, Renumathy
Genescà, Joan
Gill, Upkar S.
James, Theodore W.
Jones, Patricia D.
Marshall, Aileen
Mells, George
Perumalswami, Ponni V.
Qi, Xiaolong
Su, Feng
Ufere, Nneka N.
Barnes, Eleanor
Barritt, A. Sidney
Marjot, Thomas
author_facet Moon, Andrew M.
Webb, Gwilym J.
Aloman, Costica
Armstrong, Matthew J.
Cargill, Tamsin
Dhanasekaran, Renumathy
Genescà, Joan
Gill, Upkar S.
James, Theodore W.
Jones, Patricia D.
Marshall, Aileen
Mells, George
Perumalswami, Ponni V.
Qi, Xiaolong
Su, Feng
Ufere, Nneka N.
Barnes, Eleanor
Barritt, A. Sidney
Marjot, Thomas
author_sort Moon, Andrew M.
collection PubMed
description
format Online
Article
Text
id pubmed-7241346
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Association for the Study of the Liver. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-72413462020-05-21 High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry Moon, Andrew M. Webb, Gwilym J. Aloman, Costica Armstrong, Matthew J. Cargill, Tamsin Dhanasekaran, Renumathy Genescà, Joan Gill, Upkar S. James, Theodore W. Jones, Patricia D. Marshall, Aileen Mells, George Perumalswami, Ponni V. Qi, Xiaolong Su, Feng Ufere, Nneka N. Barnes, Eleanor Barritt, A. Sidney Marjot, Thomas J Hepatol Letter to the Editor European Association for the Study of the Liver. Published by Elsevier B.V. 2020-09 2020-05-21 /pmc/articles/PMC7241346/ /pubmed/32446714 http://dx.doi.org/10.1016/j.jhep.2020.05.013 Text en © 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Moon, Andrew M.
Webb, Gwilym J.
Aloman, Costica
Armstrong, Matthew J.
Cargill, Tamsin
Dhanasekaran, Renumathy
Genescà, Joan
Gill, Upkar S.
James, Theodore W.
Jones, Patricia D.
Marshall, Aileen
Mells, George
Perumalswami, Ponni V.
Qi, Xiaolong
Su, Feng
Ufere, Nneka N.
Barnes, Eleanor
Barritt, A. Sidney
Marjot, Thomas
High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry
title High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry
title_full High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry
title_fullStr High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry
title_full_unstemmed High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry
title_short High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry
title_sort high mortality rates for sars-cov-2 infection in patients with pre-existing chronic liver disease and cirrhosis: preliminary results from an international registry
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241346/
https://www.ncbi.nlm.nih.gov/pubmed/32446714
http://dx.doi.org/10.1016/j.jhep.2020.05.013
work_keys_str_mv AT moonandrewm highmortalityratesforsarscov2infectioninpatientswithpreexistingchronicliverdiseaseandcirrhosispreliminaryresultsfromaninternationalregistry
AT webbgwilymj highmortalityratesforsarscov2infectioninpatientswithpreexistingchronicliverdiseaseandcirrhosispreliminaryresultsfromaninternationalregistry
AT alomancostica highmortalityratesforsarscov2infectioninpatientswithpreexistingchronicliverdiseaseandcirrhosispreliminaryresultsfromaninternationalregistry
AT armstrongmatthewj highmortalityratesforsarscov2infectioninpatientswithpreexistingchronicliverdiseaseandcirrhosispreliminaryresultsfromaninternationalregistry
AT cargilltamsin highmortalityratesforsarscov2infectioninpatientswithpreexistingchronicliverdiseaseandcirrhosispreliminaryresultsfromaninternationalregistry
AT dhanasekaranrenumathy highmortalityratesforsarscov2infectioninpatientswithpreexistingchronicliverdiseaseandcirrhosispreliminaryresultsfromaninternationalregistry
AT genescajoan highmortalityratesforsarscov2infectioninpatientswithpreexistingchronicliverdiseaseandcirrhosispreliminaryresultsfromaninternationalregistry
AT gillupkars highmortalityratesforsarscov2infectioninpatientswithpreexistingchronicliverdiseaseandcirrhosispreliminaryresultsfromaninternationalregistry
AT jamestheodorew highmortalityratesforsarscov2infectioninpatientswithpreexistingchronicliverdiseaseandcirrhosispreliminaryresultsfromaninternationalregistry
AT jonespatriciad highmortalityratesforsarscov2infectioninpatientswithpreexistingchronicliverdiseaseandcirrhosispreliminaryresultsfromaninternationalregistry
AT marshallaileen highmortalityratesforsarscov2infectioninpatientswithpreexistingchronicliverdiseaseandcirrhosispreliminaryresultsfromaninternationalregistry
AT mellsgeorge highmortalityratesforsarscov2infectioninpatientswithpreexistingchronicliverdiseaseandcirrhosispreliminaryresultsfromaninternationalregistry
AT perumalswamiponniv highmortalityratesforsarscov2infectioninpatientswithpreexistingchronicliverdiseaseandcirrhosispreliminaryresultsfromaninternationalregistry
AT qixiaolong highmortalityratesforsarscov2infectioninpatientswithpreexistingchronicliverdiseaseandcirrhosispreliminaryresultsfromaninternationalregistry
AT sufeng highmortalityratesforsarscov2infectioninpatientswithpreexistingchronicliverdiseaseandcirrhosispreliminaryresultsfromaninternationalregistry
AT uferennekan highmortalityratesforsarscov2infectioninpatientswithpreexistingchronicliverdiseaseandcirrhosispreliminaryresultsfromaninternationalregistry
AT barneseleanor highmortalityratesforsarscov2infectioninpatientswithpreexistingchronicliverdiseaseandcirrhosispreliminaryresultsfromaninternationalregistry
AT barrittasidney highmortalityratesforsarscov2infectioninpatientswithpreexistingchronicliverdiseaseandcirrhosispreliminaryresultsfromaninternationalregistry
AT marjotthomas highmortalityratesforsarscov2infectioninpatientswithpreexistingchronicliverdiseaseandcirrhosispreliminaryresultsfromaninternationalregistry